Novel Biomarkers for Alzheimer’s Disease and Other Neurodegenerative Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 236
Special Issue Editors
Interests: Alzheimer’s disease; ApoE; risk factors; dementia prevention; biomarkers of neurodegeneration
Special Issue Information
Dear Colleagues,
Alzheimer's disease (AD) is an age-related neurodegenerative disorder causing severe disability and important socio-economic burden with no cure available to date. Therefore, the early detection and prevention of Alzheimer’s disease (AD) is important. The precise definition of the diagnosis and of the progression of the disease is paramount to understand how and when to act to prevent and treat neurodegeneration.
This Special Issue offers an open-access platform that aims to bring together a collection of original research and review articles addressing novel biomarkers, techniques, and approaches that will be valuable and helpful for the diagnosis or treatment of Alzheimer's disease and other neurodegenerative diseases.
We look forward to receiving your contributions.
Dr. Carlo Gabelli
Prof. Dr. Mario Plebani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer’s disease
- biomarkers
- neurodegeneration
- neuroinflammation
- miRNA
- tau
- exosomes
